Is Tuberous Sclerosis hereditary?

Tuberous Sclerosis is a genetic condition caused by mutations in the TSC1 or TSC2 genes, meaning it is hereditary in some cases but frequently arises as a new, spontaneous mutation. While it follows an autosomal dominant inheritance pattern, approximately two-thirds of individuals diagnosed with Tuberous Sclerosis do not have an affected parent, representing a de novo genetic event.

Is Tuberous Sclerosis hereditary or genetic?

Tuberous Sclerosis is both a genetic and potentially hereditary condition. It is "genetic" because it is caused by permanent changes (mutations) in the DNA of the TSC1 or TSC2 genes. It is "hereditary" when these mutations are passed down from a parent to a child. However, the distinction is important because many families discover Tuberous Sclerosis in their child without any history of the condition in either parent. In these instances, the mutation occurred spontaneously at the time of conception.

How is Tuberous Sclerosis inherited?

Tuberous Sclerosis follows an autosomal dominant inheritance pattern. This means that if a parent carries a pathogenic mutation in either the TSC1 or TSC2 gene, there is a 50% chance that any child they conceive will also inherit the mutation. Even if a parent has very mild symptoms of Tuberous Sclerosis, they still possess the same 50% risk of passing the genetic variant to their offspring. It is crucial to note that while the inheritance of the gene is dominant, the clinical severity—the way the disease manifests—can vary significantly even within the same family.

Are spontaneous (de novo) mutations common?

Yes, de novo mutations are very common in Tuberous Sclerosis. Clinical literature indicates that approximately 66% to 75% of all cases are the result of a new, spontaneous mutation that occurred in the egg or sperm cell, or very early in embryonic development. For these individuals, neither parent carries the mutation, and the risk of the condition recurring in future siblings is generally low, though slightly higher than the general population due to the possibility of parental germline mosaicism.

What is the role of genetic testing and counseling?

Genetic testing is a cornerstone of the diagnostic process for Tuberous Sclerosis. When a clinician suspects the condition based on physical symptoms, molecular genetic testing is used to identify a pathogenic variant in the TSC1 or TSC2 genes. Genetic counseling is highly recommended for all affected families to navigate the following:

• Confirmation of Diagnosis: Genetic testing can confirm the clinical diagnosis and allow for targeted screening of family members.


• Reproductive Options: Families planning pregnancies can explore options such as Preimplantation Genetic Testing (PGT) alongside In Vitro Fertilization (IVF) to select embryos without the TSC1 or TSC2 mutation.


• Understanding Risk: Counselors help interpret the 50% recurrence risk for affected parents and explain the implications of germline mosaicism.


• Prenatal Diagnosis: For parents who are known carriers, prenatal testing via amniocentesis or chorionic villus sampling (CVS) is available if desired.

Next steps

• Consult with a clinical geneticist to discuss genetic testing options for your family.


• Connect with the 351 members of the Tuberous Sclerosis community at DiseaseMaps.org to share experiences and find support.


• Request a referral to a Tuberous Sclerosis multidisciplinary clinic for comprehensive management of the condition.


• Review resources from the Tuberous Sclerosis Alliance to stay updated on current clinical trials and research.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Tuberous Sclerosis Complex.


• Orphanet: Tuberous Sclerosis.


• Online Mendelian Inheritance in Man (OMIM): Tuberous Sclerosis Complex 1 and 2.


• Tuberous Sclerosis Alliance: Clinical Guidelines and Patient Resources.